Dual inhibition of CYP17A1 and HDAC6 by abiraterone-installed hydroxamic acid overcomes temozolomide resistance in glioblastoma through inducing DNA damage and oxidative stress
- Ram Sharma
- , Yung Hsiao Chiang
- , Hsien Chung Chen
- , Hong Yi Lin
- , Wen Bin Yang
- , Kunal Nepali
- , Mei Jung Lai
- , Kai Yun Chen
- , Jing Ping Liou
- , Tsung I. Hsu
- International Ph.D. Program in Cell Therapy and Regenerative Medicine
- Taipei Neuroscience Institute
- TMU Research Center of Cell Therapy and Regeneration Medicine
- TMU Research Center of Neuroscience
- Taipei Medical University Hospital
- Master Program in Clinical Genomics and Proteomics
- Ph.D. Program in Medical Neuroscience
- Graduate Institute of Injury Prevention and Control
- Division of Neurosurgery
- Taipei Medical University Shuang Ho Hospital
- TMU Research Center of Drug Discovery
- Ph.D. Program in Drug Discovery and Development Industry
- Department of Pharmaceutical Sciences
- TMU Research Center of Cancer Translational Medicine
- TMU Research Center of Thoracic Medicine
- Ph. D. Program in the Clinical Drug Development of Herbal Medicine
- Ph.D. Program for Cancer Molecular Biology and Drug Discovery
Research output: Contribution to journal › Article › peer-review
20
Link opens in a new tab
Citations
(Scopus)